1. Home
  2. WIMI vs NXL Comparison

WIMI vs NXL Comparison

Compare WIMI & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WiMi Hologram Cloud Inc.

WIMI

WiMi Hologram Cloud Inc.

BUY

Current Price

$0.61

Market Cap

9.3M

Sector

Technology

ML Signal

BUY

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

BUY

Current Price

$2.09

Market Cap

7.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
WIMI
NXL
Founded
2015
2010
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
7.5M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
WIMI
NXL
Price
$0.61
$2.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
156.4K
★ 2.0M
Earning Date
12-18-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.76
EPS
★ N/A
N/A
Revenue
N/A
★ $301,647.00
Revenue This Year
$211.95
$14.37
Revenue Next Year
$7.11
$100.00
P/E Ratio
$1.24
★ N/A
Revenue Growth
N/A
★ 78.78
52 Week Low
$0.44
$0.22
52 Week High
$4.16
$99.00

Technical Indicators

Market Signals
Indicator
WIMI
NXL
Relative Strength Index (RSI) 32.27 31.26
Support Level N/A $0.22
Resistance Level $1.43 $5.36
Average True Range (ATR) 0.06 0.50
MACD 0.01 0.00
Stochastic Oscillator 44.35 2.06

Price Performance

Historical Comparison
WIMI
NXL

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Share on Social Networks: